LBC
BMY icon

Leigh Baldwin & Co’s Bristol-Myers Squibb BMY Stock Holding History

Leigh Baldwin & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Buy
9,200
+22
+0.2% +$1.26K 0.29% 77
2026
Q1 		$557K Sell
9,178
-1
-0% -$58 0.36% 70
2025
Q4 		$495K Sell
9,179
-1,416
-13% -$68.1K 0.33% 78
2025
Q3 		$478K Buy
10,595
+1,419
+15% +$66.3K 0.27% 91
2025
Q2 		$425K Sell
9,176
-449
-5% -$22K 0.28% 89
2025
Q1 		$587K Buy
9,625
+182
+2% +$10.6K 0.47% 54
2024
Q4 		$534K Buy
+9,443
New +$528K 0.45% 57

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Leigh Baldwin & Co's BMY Position: Q2 2026 in Review

Leigh Baldwin & Co increased its Bristol-Myers Squibb (BMY) stake by 0.24% in Q2 2026, buying an estimated $1.26K and bringing the position to 9,200 shares worth $530K. The position accounts for 0.29% of the portfolio, ranked #77.

Leigh Baldwin & Co first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $587K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Leigh Baldwin & Co held 9,200 shares of Bristol-Myers Squibb worth $530K as of Q2 2026.
  • Leigh Baldwin & Co bought 22 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.26K.
  • Bristol-Myers Squibb made up 0.29% of Leigh Baldwin & Co's portfolio in Q2 2026, its #77 holding.
  • Leigh Baldwin & Co first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Leigh Baldwin & Co's Bristol-Myers Squibb position peaked at $587K in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.